Efficacy: change in scores from baseline to endpoint (12 weeks) on symptom rating scales in the treatment of manic and mixed episodes Lower scores indicate improvement · adults with acute affective episodes in bipolar disorder
2 findings from 1 review
Efficacy: change in scores from baseline to endpoint (12 weeks) on symptom rating scales in the treatment of manic and mixed episodes Lower scores indicate improvement · adults with acute affective episodes in bipolar disorder
1 finding from 1 review
Efficacy: change in scores from baseline to endpoint (12 weeks) on symptom rating scales in the treatment of manic and mixed episodes Lower scores indicate improvement · adults with acute affective episodes in bipolar disorder
1 finding from 1 review
Intervention not reported
Improvement of motor function at the end of treatment ‐ upper and lower extremities motor function (FMA) · adults with stroke
1 finding from 1 review
Intervention not reported
Lower respiratory tract infection · People aged 60 or older living in long‐term care institutions
1 finding from 1 review
Intervention not reported
Pain on a 0 to 100 scale. Various pain scales. (lower score is better)
1 finding from 1 review
Intervention not reported
Disability on a 0 to 100 scale. Various disability scales (lower score is better)
1 finding from 1 review
Intervention not reported
Lower limb functional measures · people with stroke
The intervention showed no clear difference in lower limb functional measures (low certainty).
1 finding from 1 review
Intervention not reported
Breathlessness ‐ all trials Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies using short‐burst oxygen Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies not using short‐burst oxygen Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies measuring during exercise test Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies not measuring during exercise test Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Mean pressure gradient (mmHg) Better indicated by lower scores. · patients with aortic valve stenosis
Statin showed no clear difference in mean pressure gradient (mmHg) Better indicated by lower scores. compared with placebo (low certainty).
1 finding from 1 review
Functional ability · adults aged ≥ 65 years
1 finding from 1 review
QoL · adults aged ≥ 65 years
1 finding from 1 review
Impairment/ disability Unified Parkinson's Disease Rating Scale (UPDRS; change in global UPDRS score). Scale from: 0 to 199 (lower score means less impairment/disability) · Patients with idiopathic Parkinson's disease
1 finding from 1 review
Off time Self assessment (logfile) Scale from: 0 to 72 (lower score means less impairment/disability) · Patients with idiopathic Parkinson's disease
1 finding from 1 review
On time with dyskinesia Self assessment (logfile) Scale from: 0 to 72 (lower score means less impairment/disability) · Patients with idiopathic Parkinson's disease
1 finding from 1 review
Activity Gait speed · Patients with idiopathic Parkinson's disease
1 finding from 1 review